Navigation Links
Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting
Date:5/16/2008

Investigator to discuss assay built on VeraTag(TM) technology's ability to

predict response to Herceptin(R)

SOUTH SAN FRANCISCO, Calif., May 16 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced that scientific collaborators will present results on HERmark(TM), the company's novel oncology assay, as a means to measure HER2 and predict response to Herceptin(R) (trastuzumab) in patients with metastatic breast cancer at the upcoming 44th ASCO Annual Meeting taking place in Chicago, Illinois.

The oral presentation, entitled "Total HER2 and HER2 Homodimer Levels Predict Response to trastuzumab", which will take place on Monday, June 2, 2008 from 1:15PM - 2:45PM, will discuss the findings of a study that investigated the HERmark assay's ability to identify and discriminate among patients with metastatic breast cancer who experienced different degrees of response to trastuzumab. The results of the study, by Allan Lipton, M.D. and colleagues at the Experimental Oncology Research Lab at Penn State/Hershey Medical Center will be presented by Kim Leitzel, M.Sc., Senior Research Associate in Dr. Lipton's laboratory.

"Current testing methods for determination of the likelihood of benefit from Herceptin are not adequate," said Allan Lipton M.D., Professor of Medicine & Oncology at Hershey Medical Center/Penn State University. "HERmark represents a promising new technology that could provide enhanced information on which patient therapy decisions may be based."

"HERmark is the first diagnostic built upon our VeraTag technology," said Monogram CEO Bill Young. "We believe HERmark represents an advance in the field by providing very reproducible quantitative measures of HER2
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Monogram Biosciences Announces First Quarter 2008 Financial Results Conference Call
2. Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference
3. Raven biotechnologies Announces Collaboration With Monogram Biosciences to Advance Diagnostic Cancer Technologies
4. Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
5. Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
6. Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts
7. Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
8. Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
9. Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference
10. Monogram Announces Third Quarter 2007 Financial Results
11. Monogram Biosciences Announces Third Quarter 2007 Financial Results Conference Call

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., The New York investment...Ltd (ASX:NEU) has agreed an AU$6.7 mil convertible...investor. The private placement was arranged by KT...d advisor. , New York (PR... investment bank KTA Capital, LLC ("KTA Capit...
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-F...yannouncedthatithasreceivednoticefrom,theNasdaqSto...,suspendedasofNovember30,2009andaForm25-NSEwillbef...illremovedeCODE,scommonstock,fromlistingonNasdaq,u...lificationsPanel.Thecompanyhasfiledsuchanappeal,wh...
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-F...yannouncedtheapprovalofallofits,"firstday"motionsb...he"BankruptcyCourt").deCODElastweekfiledavoluntary...ankruptcyCodewiththe,BankruptcyCourt. , Theor...tinue,tooperateitsbusinessduringtheChapter11procee...
(Date:11/24/2009)...,, SHANGHAI,Nov.24/PRNewswire-Asia/--Shangha...nistration(SFDA)hasapprovedthe,investigationalnewd...n),aninnovativeinsulinformulationtotreatdiabetes.T...eIclinicalstudy. , Diabetesisadisordercharact...plicationsofdiabetesoftenresultinseveremicro-and,m...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2
... , , , Multiporator / Electroporat... , , Transformation Prot...002 , , , , , , ... Microorganism , Actinobacillus pleu...ell type , Bacteria, gram negative, ...
... , , , Multiporator , , ,... Transfection Protocol , Proto..., , , , , , , , ... 721.221, EBV transfected B cell line, MHC class... MHC class II positive, , , ...
... , , , Multiporator , , ,... Transfection Protocol , Proto..., , , , , , , , ... 721.174, EBV transfected B cell line, MHC class..., , , Transfection w...
Other Biology Technology:Actinobacillus pleuropneumoniae 2721.221 2721.174 2721.174 3
(Date:11/26/2009)... Whitehead researchers have developed a new type o...fic genes and proteins used by pathogens, accordin...ell cultures genes are present in two copies: one ... Gene inactivation by mutation is therefore ineffi...cond copy usually remains active and takes over. ,...
(Date:11/25/2009)...omach, may be used to boost resistance to, or slow...ool of Medicine researchers report in a study publ...ience . , Parkinson,s disease is caused by a deg...dbrain known as the substantia nigra, which is res...ion of dopamine in late-stage Parkinson,s causes s...
(Date:11/25/2009)...is the linchpin of the environment, where atmosphe... many students see soil as "just dirt" a place to...tors are challenged with the task of helping stude...ce of soil in the environment. , A collaborativ...rs at University of Nebraska-Lincoln, Oregon State...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 1New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 2New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 3New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 4The way you eat may affect your risk for breast cancer 9464 1The way you eat may affect your risk for breast cancer 9464 2The way you eat may affect your risk for breast cancer 9464 3Restoring a natural root signal helps to fight a major corn pest 9462 1Restoring a natural root signal helps to fight a major corn pest 9462 2Restoring a natural root signal helps to fight a major corn pest 9462 3
...Calif., May 12, 2009 The National Institute of Al... National Institutes of Health, has awarded UC Irv...ease research. , The renewal grant, which is the...est Regional Center of Excellence for Biodefense a...director, Dr. Alan Barbour, a UCI infectious disea...
...chine developed at North Carolina State University... after it has been removed from the animal,s body,...of new tools and techniques for heart surgery. The...ing them to test and refine their technologies in ... and time associated with animal or clinical trial...
...pacecraft launches from Cape Canaveral, Fla., in t...aining a nano-fluidics experiment designed by scie...enter at Houston. , Investigators in the laborato...director at The UT Health Science Center at Housto...ion and with it the opportunity to test a research...
Other Biology News:UCI awarded $45 million for infectious disease research 2'Beating' heart machine expedites research and development of new surgical tools, techniques 2UT nanomedicine project to be tested in space 2
Standard and Modified Oligonucleotides Service from Yorkshire Bioscience Ltd
...20 years of expertise in the field of Enzyme-Linke...he most powerful systems on the market. Freedom EV...requiring incubation and washing steps. The inte...aker incubators, reader,washer), all controlled by...
...d Choice Microsphere/Microarray Stabilizer is a is...lus Stabilizer. This product is an aqueous soluti...er (phosphate buffered saline), pH 6.6 - 7.2. Thi...othiazolone and 0.02% bromonitrodioxane as a prese...
Rabbit Anti-JKK / SEK1 / MKK4, phospho Antibody, Unconjugated from MBL International
Biology Products: